Action TMCI TREACE MEDICAL CONCEPTS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Treace Medical Concepts, Inc.

Actions

TMCI

US89455T1097

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 10/06/2024 		Varia. 5j. Varia. 1 janv.
5,75 USD -2,71 % Graphique intraday de Treace Medical Concepts, Inc. +4,93 % -54,90 %
29/05 Un initie de Treace Medical Concepts a achete des actions d'une valeur de 253 475 $, selon un recent depot aupres de la SEC MT
16/05 TREACE MEDICAL CONCEPTS, INC. : UBS neutre sur le dossier ZM

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Treace to Present at Truist Securities MedTech Conference
AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
BU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Treace Medical Concepts: Q1 Earnings Snapshot
AQ
Treace Medical Concepts Reports First Quarter 2024 Financial Results
AQ
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
AQ
Treace to Present at Bank of America Health Care Conference
GL
Treace Announces First Annual National Bunion Day
GL
Treace to Report First Quarter 2024 Financial Results
GL
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
GL
Treace Medical Concepts: Q4 Earnings Snapshot
AQ
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
GL
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
GL
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
GL
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
GL
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
AQ
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
GL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action TMCI
  4. Actualités Treace Medical Concepts, Inc.
  5. Communiqués